Arnaud Dieudonné

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

Hugo Levillain, Oreste Bagni, Christophe M. Deroose et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 245 citations · Full text

Medicine, Nuclear Medicine, Radiology +16

Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with ⁹⁰Y in the SARAH Study

Anne-Laure Hermann, Arnaud Dieudonné, Maxime Ronot et al. · Radiology · 2020 · 198 citations

Medicine, Nuclear Medicine, Oncology +17

[18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis

A. Justet, Astrid Laurent-Bellue, Gabriel Thabut et al. · Respiratory Research · 2017 · 117 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Study of the Impact of Tissue Density Heterogeneities on 3-Dimensional Abdominal Dosimetry: Comparison Between Dose Kernel Convolution and Direct Monte Carlo Methods

Arnaud Dieudonné, Robert F. Hobbs, Rachida Lebtahi et al. · Journal of Nuclear Medicine · 2012 · 85 citations · Full text

Medicine, Nuclear Medicine, Oncology +17